Answers are grounded in this paper and cite their sources.
Preclinical study reveals that an inactivated phase I Coxiella burnetii vaccine induces protective cellular immunity in guinea pigs, highlighting its efficacy against virulent infection.
The ability of a killed phase I Coxiella burnetii vaccine to induce cell-mediated immune responses in guinea pigs was studied. Cell-mediated immune responses were assessed by the inhibition of macrophage migration and lymphocyte transformation assays. The macrophage migration response occurred rapidly and was detected at high levels, but was relatively short-lived. In contrast, the lymphocyte transformation response developed more slowly, and persisted for a longer period. The vaccine, given in a single dose or in two doses 1 week apart, protected guinea pigs from a subsequent virulent challenge.
No takes yet. Share an insight, caveat, or question.
Kishimoto et al. (1978) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: